Physician profile
Anthony Echo
NPI 1700027745
$27,002.86
in general payments reported to CMS, 2019-2025
29 companies · $522 in 2025
The $522 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $3,601 · 2021: $962 · 2022: $1,994 · 2023: $1,410 · 2024: $523 · 2025: $522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,456.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $18,488.03 | 2019-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Cap |
| Sientra, INC. | $1,488.26 | 2019-2022 | |
| Alafair Biosciences, INC. | $1,363.58 | 2022-2025 | Versawrap |
| Mentor Worldwide LLC | $1,068.13 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Checkpoint Surgical, INC | $1,021.00 | 2019-2025 | Checkpoint Stimulators |
| Allergan, INC. | $626.87 | 2019-2022 | |
| Galderma Laboratories, L.P. | $450.00 | 2019 | |
| Tela Bio, INC. | $434.66 | 2019-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Integra Lifesciences Corporation | $425.62 | 2020-2025 | Cytal |
| Ethicon US, LLC | $196.25 | 2020-2025 | Stratafix, Evarrest, Vistaseal |
| Medtronic, INC. | $171.98 | 2022-2024 | V-Loc 180 |
| Biotissue Holdings INC. | $150.58 | 2025 | |
| Tepha INC | $148.21 | 2020 | |
| Tei Biosciences INC | $144.98 | 2019 | |
| Abbvie INC. | $131.57 | 2024 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $115.38 | 2019 | |
| Bone Support INC. | $83.57 | 2024 | Ceramentbone Void Filler, Cerament G |
| Vertex Pharmaceuticals Incorporated | $82.07 | 2024-2025 | |
| Smith+Nephew, INC. | $69.46 | 2023-2024 | Stravix Pl, Oasis |
| Stryker Corporation | $60.91 | 2021 | |
| Depuy Synthes Sales INC. | $52.72 | 2023-2024 | Matrixmidface |
| Pacira Pharmaceuticals Incorporated | $46.41 | 2021-2023 | Exparel |
| Musculoskeletal Transplant Foundation INC. | $45.91 | 2021-2023 | |
| Medical Device Business Services, INC. | $38.21 | 2022-2023 | Vistaseal |
| Coopersurgical, INC. | $29.10 | 2020-2025 | Insorb |
| Biom'Up France Sas | $22.23 | 2021 | |
| Polarityte, INC. | $22.01 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.89 | 2023 | Seglentis |
| Bsn Medical INC | $11.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$884,010.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Echo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.